AbbVie Inc. (BKK:ABBV19)

AbbVie Statistics

Total Valuation

AbbVie has a market cap or net worth of THB 13.39 trillion. The enterprise value is 15.43 trillion.

Market Cap	13.39T
Enterprise Value	15.43T

Important Dates

The last earnings date was Friday, October 31, 2025.

Earnings Date	Oct 31, 2025
Ex-Dividend Date	Oct 15, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	0.07%
Owned by Institutions (%)	74.04%
Float	1.76B

Valuation Ratios

The trailing PE ratio is 175.55 and the forward PE ratio is 17.09.

PE Ratio	175.55
Forward PE	17.09
PS Ratio	6.91
PB Ratio	-158.59
P/TBV Ratio	n/a
P/FCF Ratio	20.94
P/OCF Ratio	19.76
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.96, with an EV/FCF ratio of 24.14.

EV / Earnings	202.40
EV / Sales	7.99
EV / EBITDA	15.96
EV / EBIT	22.41
EV / FCF	24.14

Financial Position

The company has a current ratio of 0.72

Current Ratio	0.72
Quick Ratio	0.47
Debt / Equity	n/a
Debt / EBITDA	2.31
Debt / FCF	3.50
Interest Coverage	7.38

Financial Efficiency

Return on equity (ROE) is 137.96% and return on invested capital (ROIC) is 18.50%.

Return on Equity (ROE)	137.96%
Return on Assets (ROA)	9.59%
Return on Invested Capital (ROIC)	18.50%
Return on Capital Employed (ROCE)	22.50%
Revenue Per Employee	35.22M
Profits Per Employee	1.39M
Employee Count	55,000
Asset Turnover	0.43
Inventory Turnover	3.63

Taxes

Income Tax	-23.87B
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	59.98
Average Volume (20 Days)	52,084

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.35

Income Statement

In the last 12 months, AbbVie had revenue of THB 1.94 trillion and earned 76.25 billion in profits. Earnings per share was 42.89.

Revenue	1.94T
Gross Profit	1.38T
Operating Income	690.56B
Pretax Income	53.91B
Net Income	76.25B
EBITDA	958.60B
EBIT	690.56B
Earnings Per Share (EPS)	42.89

Balance Sheet

The company has 184.16 billion in cash and 2.24 trillion in debt, giving a net cash position of -2,051.64 billion.

Cash & Cash Equivalents	184.16B
Total Debt	2.24T
Net Cash	-2,051.64B
Net Cash Per Share	n/a
Equity (Book Value)	-84.40B
Book Value Per Share	-48.55
Working Capital	-352.41B

Cash Flow

In the last 12 months, operating cash flow was 677.41 billion and capital expenditures -38.19 billion, giving a free cash flow of 639.22 billion.

Operating Cash Flow	677.41B
Capital Expenditures	-38.19B
Free Cash Flow	639.22B
FCF Per Share	n/a

Margins

Gross margin is 71.46%, with operating and profit margins of 35.65% and 4.00%.

Gross Margin	71.46%
Operating Margin	35.65%
Pretax Margin	2.78%
Profit Margin	4.00%
EBITDA Margin	49.49%
EBIT Margin	35.65%
FCF Margin	33.00%

Dividends & Yields

This stock pays an annual dividend of 0.04, which amounts to a dividend yield of 0.58%.

Dividend Per Share	0.04
Dividend Yield	0.58%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	481.49%
Buyback Yield	-0.01%
Shareholder Yield	0.57%
Earnings Yield	0.57%
FCF Yield	4.78%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AbbVie has an Altman Z-Score of 2.21 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.21
Piotroski F-Score	7